Latest filing published 23 Nov 2021 for Theravance Biopharma, Inc., €32k.
Filing timeline
BuySaleInsider track record
Philip D. Worboys: trading record in brief
Philip D. Worboys (senior executive) discloses dealings in Theravance Biopharma, Inc. to SEC (Form 4). The record holds 36 filings, for trades running from 15 March 2016 to 19 November 2021.
On the market, this insider has only sold: 4 sales, €628k in total. The rest of the record consists of 32 share grants. In 2021 alone, the filings show no purchases and 1 sale.
Most recently, on 23 November 2021, the filings show a share grant worth €32k in Theravance Biopharma, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Philip D. Worboys
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,310 shares@ US$8.3621.7% of flowOrdinary SharesSEC:0001415889-21-005465:0
- 4,307 shares@ US$14.0535.4% of flowOrdinary SharesSEC:0001179110-21-008406:0
- 4,310 shares@ US$17.8042.9% of flowOrdinary SharesSEC:0001179110-21-005854:0
- 8,829 shares@ US$20.003.6% of flowOrdinary SharesSEC:0001179110-21-003282:0
- 31,887 shares@ US$18.7912.1% of flowOrdinary SharesSEC:0001179110-21-002178:0
- 65,000 shares0Ordinary SharesSEC:0001179110-21-001542:0
- 4,246 shares@ US$18.004.4% of flowOrdinary SharesSEC:0001179110-20-011737:0
- 4,807 shares@ US$17.214.9% of flowOrdinary SharesSEC:0001179110-20-011379:0
- 17,103 shares@ US$18.0018.2% of flowOrdinary SharesSEC:0001179110-20-009277:0
- 4,804 shares@ US$18.225.2% of flowOrdinary SharesSEC:0001179110-20-009277:1
- 4,807 shares@ US$26.678.0% of flowOrdinary SharesSEC:0001179110-20-006538:0
- 29,105 shares@ US$25.9046.3% of flowOrdinary SharesSEC:0001179110-20-002158:0
- 65,000 shares0Ordinary SharesSEC:0001179110-20-001212:0
- 54,000 shares0Ordinary SharesSEC:0001179110-20-001212:1
- 2,272 shares@ US$17.601.8% of flowOrdinary SharesSEC:0001179110-19-012025:0
- 2,272 shares@ US$21.512.2% of flowOrdinary SharesSEC:0001179110-19-009800:0
- 2,272 shares@ US$19.841.7% of flowOrdinary SharesSEC:0001179110-19-006541:0
- 3,986 shares@ US$27.003.7% of flowOrdinary SharesSEC:0001179110-19-002435:0
- 65,000 shares0Ordinary SharesSEC:0001179110-19-001574:0
- 47,250 shares0Ordinary SharesSEC:0001179110-19-001574:1
- 4,373 shares@ US$24.793.7% of flowOrdinary SharesSEC:0001179110-18-013112:0
- 6,393 shares@ US$28.505.9% of flowOrdinary SharesSEC:0001179110-18-011431:0
- 5,508 shares@ US$26.954.8% of flowOrdinary SharesSEC:0001179110-18-010824:0
- 19,524 shares@ US$24.3111.7% of flowOrdinary SharesSEC:0001179110-18-007377:0
- 33,750 shares0Ordinary SharesSEC:0001179110-18-006941:0
25 of 36 declarations
